Dr. Quan, Dr. Mirhashemi, Dr. Chiang

Slides:



Advertisements
Similar presentations
Is Carotid Stenting an Option for Treatment of Carotid Stenosis? Joint Hospital Surgical Grand Round WH WONG Queen Mary Hospital.
Advertisements

Stenting and Angioplasty with Protection in Patients at High-Risk for Endarterectomy Presented by Jay Yadav, MD on behalf of the SAPPHIRE Investigators.
Journal Club Ani Balmanoukian and Peter Benjamin November 9, 2006 Journal Club Ani Balmanoukian and Peter Benjamin November 9, 2006.
Carotid Endarterectomy versus Stenting: Where do we stand today? Vascular Conference March 23, 2010.
Endovascular Management of Intracranial and Extracranial Atherosclerosis Rishi Gupta, MD Associate Professor of Neurology, Neurosurgery, and Radiology.
Rashad MAHMUDOV Central Hospital of Oilworkers, Baku-Azerbaijan
VBWG CHARISMA Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance trial.
Endarterectomy versus Stenting in Patients with Symptomatic Severe Carotid Stenosis Dr. Quan, Dr. Mirhashemi, Dr. Chiang N Engl J Med 2006; 355:
Terutroban versus aspirin in Patients with Cerebral Ischaemic Events (PREFORM): a Randomized, Double- blind Parallel-group Trial Daniel Wells Mercer University.
Samsung Medical Center Sungkyunkwan University School of Medicine Hyeon-Cheol Gwon, Joo Yong Hahn, Young Bin Song, Kyung Woo Park, Yang Soo Jang, Hyo-Soo.
Atherosclerotic Disease of the Carotid Artery Atherosclerosis is a degenerative disease of the arteries resulting in plaques consisting of necrotic cells,
Endovascular treatment on tandem lesions of cranial arteries Xiao-Long Zhang, MD, PhD Department of Radiology Huashan Hospital,Fudan University Shanghai.
CHU C A E N EVA-3S Inferences and future directions Jacques Theron, MD Martial Hamon, MD.
The ACTIVE Investigators. N Engl J Med 2009 Apr 3 [Epub]
Antithrombotic Trialists’ Collaboration An updated collaborative overview of randomised trials of antiplatelet therapy among high-risk patients.
: PROFI : A Prospective, Randomized Trial of Proximal Balloon Occlusion vs. Filter Embolic Protection in Patients Undergoing Carotid Stenting Klaudija.
Hypothesis: baseline risk status of the patients and proximity to a recent cardiovascular event influence the response to dual anti-platelet therapy. Patients.
ANGIOPLASTY & STENTING FOR EXTRACRANIAL & INTRACRANIAL ATHEROSCLEROTIC DISEASE 2010 UPDATE MICHEL E. MAWAD, M.D. PROFESSOR & CHAIR DEPARTMENT OF RADIOLOGY.
Rikki Weems, PGY III August 20, 2015
Carotid Disease – Stent vs Surgery vs Medical Therapy? Mehdi H. Shishehbor, DO, MPH, PhD Director, Endovascular Services Interventional Cardiology & Vascular.
The JUPITER Trial Reference Ridker PM. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med. 2008;359:2195–2207.
CAROTID ARTERY ENDARTHERECTOMY &INTERVENTION
Ten Year Outcome of Coronary Artery Bypass Graft Surgery Versus Medical Therapy in Patients with Ischemic Cardiomyopathy Results of the Surgical Treatment.
Faramarz Amiri MD IUMS.  Severe carotid disease (defined as >80%) 8–12%  Severe carotid disease (>70%) in those with three vessel or left main coronary.
Review on NOACs Studies DR. KOUROSH SADEGHI TEHRAN UNIVERSITY OF MEDICAL SCIENCES.
Emerging Techniques For Management of Carotid and Brachiocephalic Occlusive Disease for Prevention of Stroke Brian Whang, Romeo Mateo, Anthony Pucillo,
(p for noninferiority = 0.01)
Case 66 year old male with PMH of HTN, DM, ESRD on renal replacement TIW, stroke in 2011 with right side residual weakness, atrial fibrillation, currently.
Anticoagulation after peripheral Vascular Intervention
Table 1: Table 2: Non Therapeutic Angiograms in Acute Ischemic Stroke Patients Being Considered for Endovascular Treatment Does not Adversely Affect Patient.
The American College of Cardiology Presented by Dr. Adnan Kastrati
Bedside monitoring to adjust antiplatelet therapy for Coronary stenting N Engl J Med Nov 29;367: Prof. Soo-Joong Kim / R3 Yu Ho Lee.
CRT 2017: Putting LAA closure in the age of DOACs into perspective
Transcatheter or Surgical Aortic Valve Replacement in Intermediate Risk Patients with Aortic Stenosis Description: The goal of the trial was to assess.
Recent Update on Carotid Endarterectomy versus Carotid Artery Stenting
Carotid Artery Stenosis
Damian Gimpel Waikato Cardiothoracic Unit Journal Club
CQC Amit Gossain.
The European Society of Cardiology Presented by Dr. Bo Lagerqvist
Larissa Registry on CAS and CEA:
HOPE: Heart Outcomes Prevention Evaluation study
Cardiovascular Research Technology Conference (CRT 17)
LONG-DES II Trial Randomized Comparison of the Efficacy of Sirolimus-Eluting Stent Versus Paclitaxel-Eluting Stent in the Treatment of Long Native Coronary.
Pooled Analysis of VA, ACAS, ACST-1 & GALA Trials
POISE-2 PeriOperative ISchemic Evaluation-2 Trial
PMA Analysis of the CREST Trial Approvability of the RX Acculink Carotid Stent System for Revascularization of Carotid Artery Stenosis in Standard Surgical.
SPIRE Program: Studies of PCSK9 Inhibition and the Reduction of Vascular Events Unanticipated attenuation of LDL-c lowering response to humanized PCSK9.
Randomized Evaluation of Long-term anticoagulant therapY
Cardiovacular Research Technologies
ACTIVE A Effects of Addition of Clopidogrel to Aspirin in Patients with Atrial Fibrillation who are Unsuitable for Vitamin K Antagonists.
The following slides highlight a presentation at the Late-Breaking Clinical Trials session of the American Heart Association Scientific Sessions, November.
Symptomatic vs. Asymptomatic Carotid Endarterectomy
Dabigatran in myocardial injury after noncardiac surgery
Modified Rankin score 0-2
Giuseppe Biondi Zoccai, MD
NIPPON Trial design: Patients undergoing percutaneous coronary intervention were randomized to short-term dual antiplatelet therapy (DAPT) (6 months; n.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
An Analysis of the ACUITY Trial Lincoff AM, JACC Intv 2008;1:639–48
FOURIER Trial design: Patients with established cardiovascular disease on statin therapy were randomized to evolocumab 140 mg subcutaneous every 2 weeks.
(p < for noninferiority)
(p = for noninferiority)
Carotid Stenting in Acute Ischemic Stroke Resulting from Tandem Occlusions STEWART WEBER, MD.
The Synergy between Percutaneous Coronary Intervention with TAXUS and Cardiac Surgery: The SYNTAX Study One Year Results of the PCI and CABG Registries.
Correlation between endothelial function and hypertension
Volume 375, Issue 9719, Pages (March 2010)
DEScover: One-Year Clinical Results
SPIRE Program: Studies of PCSK9 Inhibition and the Reduction of Vascular Events Unanticipated attenuation of LDL-c lowering response to humanized PCSK9.
Section C: Clinical trial update: Oral antiplatelet therapy
Update from education committee
Transcarotid Artery Revascularization versus Transfemoral Carotid Artery Stenting for Treatment of Carotid Artery Stenosis Patric Liang, MD; Marc L.
Presentation transcript:

Dr. Quan, Dr. Mirhashemi, Dr. Chiang Endarterectomy versus Stenting in Patients with Symptomatic Severe Carotid Stenosis Dr. Quan, Dr. Mirhashemi, Dr. Chiang N Engl J Med 2006; 355:1660-71

Objective Know when to send patients for carotid artery stenting vs endarterectomy Learn about Relative Risk Know when is Relative Risk significant

Overview Step 1 – Get patients with symptomatic carotid stenosis Step 2 – Send patients to have carotid stenting or endarterectomy Step 3 – Evaluate 30-day stroke or death of both groups

Purpose To evaluate the efficacy of carotid stenting vs endarterectomy in patients with symptomatic carotid-artery stenosis

Time and Place November 2000 to September 2005 20 academic and 10 non-academic centers in France Approved by ethics committee

Centers and Investigators 1+ Neurologist 1+ Vascular Surgeon Performed 25 endarterectomies 1+ Interventional Physician Performed 12 carotid-stenting or Performed 35 stenting procedures in supraaortic trucks (5 in carotid artery)

Patients 18+ years old Hemispheric or retinal TIA or nondisabling stroke within 120 days Carotid Artery Stenosis of 60 to 99% Confirmed by angiography or both duplex scanning and MRA

Reference: http://neuro.wehealny.org/endo/proc_stents-angioplasty.asp

Reference: http://www. diagnosticclinic

Excluded Patients Modified Rankin score of 3+ Nonatherosclerotic carotid disease Severe tandem lesions (proximal common carotid artery or intracranial artery that was more severe than carotid lesion) Previous revascularization History of bleeding disorder

Excluded Patients Uncontrolled HTN or DM Unstable Angina Contraindication to heparin, ticlopidine, or clopidogrel Life expectancy of less than 2 years Percutaneous or surgical intervention within 30 days

Standard Procedures Surgeons performed endarterectomy according to customary practice Carotid stenting via femoral route with the use of cerebral protection device (01/2003 approved by safety committee)

Cerebral Protection Device Reference: http://radinfo.musc.edu/Interventional/index.php?module=pagemaster&PAGE_user_op=view_page&PAGE_id=58

Endarterectomy Reference: http://radinfo.musc.edu/Interventional/index.php?module=pagemaster&PAGE_user_op=view_page&PAGE_id=58

Anticoagulation Aspirin 100-300mg qd Clopidogrel 75 mg qd or Ticlopidine 500mg qd Take 3 days before and 30 days after stenting

Follow-up 48 hours 30 days 6 months after treatment Then every 6 months thereafter

End Points Any stroke or death occurring within 30 days after treatment

Results

Predicted Statistics Require 872 patients whether stenting was not inferior to endarterectomy with regard to the 30-day incidence of stroke or death Expected 30-day incidence of stroke or death (Endarterectomy 5.6%, Stent 4%)

Local Injuries Cranial-nerve injury was significantly more common after endarterectomy than after stenting (7.7% vs 1.1%, P<0.001) Median hospital stay (stent, 3 days, endarterectomy – 4 days, P=0.01)

Weakness by Dr. Mirhashemi

Strengths Baseline patients characteristics in stenting vs endarterectomy are statistical similar

Adjusted Relative Risk Age – 2.4 History of stroke – 2.6 More patients in the stenting group had contralateral carotid occlusion; none of them had a stroke after stenting

Strength Computer-generated sequence randomly assigned to undergo endarterectomy or stenting Operator independent

Learning Curve No significant differences in outcome related to the number of stenting procedures performed in individual centers or to the experience of the interventional physicians Experience with any new device was required before its use in the trial

Effects of Cerebral Protection 30-day incidence of stroke or death was lower among patients who underwent stenting with cerebral protection (7.9%) than stenting alone (25%) However, the RR over endarterectomy did not differ significantly (2.0 before and 3.4 after)

Antiplatelet Therapy 30-day incidence of stroke or death after stenting didn’t differ significantly between pts who received dual antiplatelet therapy (19 of 211, 9.0%) and those who received single antiplatelet therapy (4 of 36, 11.1%, P=0.75)

Strengths The events committee assess the occurrence of stroke, death, and other outcomes, unaware of the treatment assignments

Discussion Lower surgical risk in our study Previous trials – 30-day incidence of stroke or death after endovascular repair of the carotid artery is 8.1% (51 of 632)

Stenting 30-day incidence of stroke after stenting in our study 9.2% which was higher than SAPPHIRE trial 3.6% (most patients had asymptomatic stenosis)

Safety and Futility September 2005, safety committee recommended stopping enrollment due to increased risk of stroke or death after stenting and requiring to enroll more than 4000 patients to test the noninferiority of stenting

Conclusion Patients with symptomatic carotid stenosis of 60% or more, treatment with endarterectomy results in lower rates of stroke or death at 30days and 6 months than does stenting.

THANK YOU…